SubHero Banner

Qbrelis (lisinopril) – New drug approval

July 29, 2016 – Silvergate announced the FDA approval of Qbrelis (lisinopril) oral solution, for three indications: treatment of hypertension in adult patients and pediatric patients ≥ 6 years of age to lower blood pressure, to reduce signs and symptoms of systolic heart failure, and for the reduction of mortality in treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction (AMI).

Download PDF